Would you like to learn a simple strategy to avoid these wasteful activities?
Repeated and sporadic rounds of firefighting
Scroll down to find out more
Trial-and-error is a common approach to resolving quality issues during the development and manufacture of liquid dispersions in many industries.
Repeated and sporadic rounds of firefighting cause unpredictable delays and unnecessary expenditure, compromising the development, approval, production and robustness of a wide range of products.
Apply fundamental concepts of colloid science
Improve quality of your liquid dispersions
Significantly reduce human resource, time and cost
Increase your bottom line
I don't have time to do this!
"Colloid science is too complicated and theoretical."
"We've tried it before - it didn't help."
"I simply don't have time!"
This course is different
This course is short
This course is straightforward
This course is practical
This course is free
This course is for you
How is this course different?
This course has been developed based on 24 years of experience of applying colloid science in the pharmaceutical industry.
It expertly lays down a foundation of essential colloid science in a digestible manner.
It will help you develop and maintain robust industrial products.
How is this course short?
This course has been crafted to teach just the essentials to create a strategy for reducing firefighting and cost-of-poor-quality.
It will take you an hour or so to complete.
How is this course straightforward?
The fundamental aspects of colloid science are taught concisely with clarity. Emphasis is on the phenomena and how they can affect the quality of the product.
There's no mathematics.
Other courses provide too much content and detail, creating the impression that colloid science is too complicated to be of realistic value.
How is this course practical?
Why is this course for me?
If you need to stop firefighting
If you need to reduce costs
If you need to increase quality and robustness
YOU need to take THIS course
"Excellent! The technical content is superb and the delivery using a mix of video, text and quizzes is fabulous."
- Jim Kennady, Materials Science Lead, GlaxoSmithKline
"The course objectives are clear and well written as is the course material itself. John explains the concepts in a simple and concise way, including the theoretical aspects. Highly recommended!"
- Derek HH. Chan, Department of Chemistry, University of Sheffield
"It was John’s scientific breakthroughs on resolving pharmaceutical performance issues with Advair MDI that enabled its approval and launch in 2006. "
- Loy Britto, Global Product Owner and Director, GlaxoSmithKline
"A huge thank you to you for all the wonderful science and original thinking you have brought to product development and manufacturing over the years."
- Jo Craig, Senior Vice President (CMC), KaNDy Therapeutics
"John is one of the most impressive scientists that I have had the pleasure of working with. He has the fortunate combination of being a brilliant scientist while at the same time being practical and applies his training and experience to resolve complex real world pharma problems in a well-thought out, efficient, approach."
- William L. Roberts, Principal Scientist, Vast Therapeutics
"John is an incredibly capable scientist and a terrific person with a trademark honesty, courage, and commitment to sharing his talents with the world."
- Ted Benson, Co-founder and Managing Partner, Corralling Chaos
I founded ENLIGHTEN SCIENTIFIC after 24-years in the pharmaceutical industry. I spent most of my time on late phase formulation and device development of metered-dose inhalers (MDIs). This is one of the most — if not the most — complex delivery platforms. In the early 2000s, I led the development and approval of one of the most successful North American MDI products — ADVAIR® HFA Inhalation Aerosol. In the mid-2010s, I transitioned to the manufacturing organization. MDIs require very careful supply change control and it was common for arising issues to be dealt with in a trial-and-error way. In contrast, I used my colloid science expertise to identify and implement much more robust solutions with significantly less resource. The experiences and expertise gained working with MDIs proved valuable for helping resolve issues with other dosage forms. I became a technical expert for many international product development and manufacturing teams.
Prior to starting my career in the pharmaceutical industry, I obtained my PhD in colloid science at the University of Bristol, widely recognized as one of the premier world-class centers of excellence for colloid and interface science. For my research, I invented Phase Analysis Light Scattering (PALS) which is now the de facto method for determining the zeta potential of dilute liquid dispersions. Major manufacturers of PALS instruments include Malvern Panalytical, Brookhaven Instruments, and Wyatt Technologies.
Enroll now for a chance to win one hour of FREE consulting